Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.55 |
| ▸ | FPR2 | P25090 | 2/20 | 0.54 |
| ▸ | MTOR | P42345 | 3/20 | 0.52 |
| ▸ | NAMPT | P43490 | 1/20 | 0.51 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | PIM1 | P11309 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23328666 | 0.88 | EPHX2 (0.57) | MEN1KMT2AEPHX2FPR2MTOR | |
| SCHEMBL23328673 | 0.87 | MEN1 (0.63) | MEN1KMT2AEPHX2FPR2MTOR | |
| SCHEMBL25841022 | 0.86 | FPR2 (0.49) | MEN1KMT2AEPHX2FPR2MCHR1 | |
| SCHEMBL23328722 | 0.86 | MEN1 (0.61) | MEN1KMT2AEPHX2FPR2MTOR | |
| SCHEMBL23328720 | 0.85 | CDK1 (0.55) | MEN1KMT2AEPHX2FPR2TRPV1 | |
| SCHEMBL23328392 | 0.84 | EPHX2 (0.64) | MEN1KMT2AEPHX2MTORNAMPT | |
| SCHEMBL13480539 | 0.76 | MEN1 (0.77) | MEN1KMT2AEPHX2FPR2MTOR | |
| SCHEMBL23328445 | 0.76 | MEN1 (0.67) | MEN1KMT2AEPHX2MTORNAMPT | |
| SCHEMBL23328875 | 0.76 | KMT2A (0.63) | MEN1KMT2AEPHX2TRPV1HTT | |
| SCHEMBL23328371 | 0.75 | CDK1 (0.59) | MEN1KMT2AEPHX2TRPV1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11701333-B2 | Antibacterial compounds | Kent Innovation & Enterprise (GB) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11701333-B2 | Antibacterial compounds | ARF1, ARL1, TLR1 | MEN1 1300/4885KMT2A 2533/4885EPHX2 2581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.